Hydrocortisone Acetate Suppository shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-07-23 · last update 2026-07-23
Manufacturers: Padagis US LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
| Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)